Pfizer Inc and its German accomplice BioNTech SE will search emergency use authorization for a second booster shot of their COVID-19 vaccine for individuals aged 65 and older, the Washington Submit reported on Tuesday.
The submission to the U.S. Meals and Drug Administration, anticipated as quickly as Tuesday, is predicted to incorporate “actual world knowledge” collected in Israel, one of many few nations that has approved a second booster for older individuals, the report mentioned, citing individuals conversant in the matter.
Pfizer and BioNtech’s two-dose vaccine has proven to be efficient in opposition to extreme illness and loss of life attributable to the heavily-mutated Omicron variant, however much less efficient in stopping transmission.
Chief Government Officer Albert Bourla has mentioned there may be want for extra booster doses as immunity wanes.
Each the businesses didn’t instantly reply to Reuters request for remark.
(Reporting by Mrinalika Roy in Bengaluru; Modifying by Shinjini Ganguli and Amy Caren Daniel)
U.S. FDA has now accepted Pfizer’s COVID-19 booster shot for 12- to 15-year-olds